DENTSPLY SIRONA Inc.

Informe acción NasdaqGS:XRAY

Capitalización de mercado: US$3.3b

DENTSPLY SIRONA Dirección

Dirección controles de criterios 2/4

El CEO de DENTSPLY SIRONA es Simon Campion , nombrado en Sep 2022, tiene una permanencia de 2.67 años. compensación anual total es $8.68M, compuesta por 11.8% salario y 88.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.07% de las acciones de la empresa, por valor de $2.33M. La antigüedad media del equipo directivo y de la junta directiva es de 1.4 años y 4.7 años, respectivamente.

Información clave

Simon Campion

Chief Executive Officer (CEO)

US$8.7m

Compensación total

Porcentaje del salario del CEO11.78%
Permanencia del CEO2.7yrs
Participación del CEO0.07%
Permanencia media de la dirección1.4yrs
Promedio de permanencia en la Junta Directiva4.7yrs

Actualizaciones recientes de la dirección

DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

May 15
DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

Recent updates

DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

May 15
DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

Earnings Beat: DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 11
Earnings Beat: DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 09
DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
author-image

Revamped E-commerce And Imaging Products Will Secure Success

Strategic divestment of Wellspect HealthCare aims to unlock value and improve net margins, leveraging its growth and profitability.

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Apr 29
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Apr 08
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16

Mar 18
DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16

Weak Results And Poor Growth Prospects Have Dentsply Sirona Deep In The Street's Doghouse

Mar 05

Benign Growth For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Underpins Its Share Price

Feb 13
Benign Growth For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Underpins Its Share Price

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Somewhat Strained Balance Sheet

Jan 08
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Dec 21
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 40% Below Their Intrinsic Value Estimate

Dec 03
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 40% Below Their Intrinsic Value Estimate

Dentsply Sirona: No Change To Operating Mechanics Despite Extensive Review

Nov 27

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Simon Campion en comparación con los beneficios de DENTSPLY SIRONA?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2025n/an/a

-US$908m

Dec 31 2024US$9mUS$1m

-US$910m

Sep 30 2024n/an/a

-US$413m

Jun 30 2024n/an/a

-US$185m

Mar 31 2024n/an/a

-US$95m

Dec 31 2023US$9mUS$1m

-US$132m

Sep 30 2023n/an/a

-US$214m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023n/an/a

-US$1b

Dec 31 2022US$8mUS$304k

-US$950m

Compensación vs. Mercado: La compensación total ($USD8.68M) de Simon está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD7.42M).

Compensación vs. Ingresos: La compensación de Simon ha aumentado mientras la empresa no es rentable.


CEO

Simon Campion (52 yo)

2.7yrs
Permanencia
US$8,683,952
Compensación

Mr. Simon D. Campion serves as Chief Executive Officer at DENTSPLY SIRONA Inc. since September 12, 2022 and also serves as its President & Director since September 2022 & was its Interim CFO since November...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Simon Campion
CEO, President & Director2.7yrsUS$8.68m0.070%
$ 2.3m
Richard Rosenzweig
Executive VP of Corporate Development2.3yrsUS$2.51m0.012%
$ 399.7k
Robert Johnson
Senior VP & Chief Supply Chain Officer and Head of Sustainability1.1yrsUS$2.23m0.023%
$ 778.2k
Herman Cueto
Interim Chief Financial Officerless than a yearsin datossin datos
Kevin Czerney
Vice President & Chief Accounting Officerless than a yearsin datos0.013%
$ 437.1k
Kevin Boyle
Senior VP & Chief Technology Officer1.4yrssin datossin datos
Andrea Daley
Vice President of Investor Relationsno datasin datossin datos
Andrea Frohning
Senior VP & Chief Human Resources Officer1.8yrssin datos0.0030%
$ 100.4k
Emily Miner
Senior VP of Global Quality and Regulatory & Chief Quality Officer2yrssin datossin datos
David Ferguson
Senior Vice President of Global Business Unit Leaderless than a yearsin datossin datos
Dane Baumgardner
Attorney-In-Factno datasin datossin datos
Gerard Campbell
Group Vice President for EMEA RCOno datasin datossin datos
1.4yrs
Permanencia media
53yo
Promedio de edad

Equipo directivo experimentado: El equipo directivo de XRAY no se considera experimentado ( 1.4 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Simon Campion
CEO, President & Director2.7yrsUS$8.68m0.070%
$ 2.3m
Clyde Hosein
Independent Director4.7yrsUS$320.00k0.0092%
$ 304.2k
Betsy Holden
Independent Director7.3yrsUS$335.00k0.0014%
$ 45.1k
Leslie Varon
Independent Director7.3yrsUS$345.00k0.013%
$ 424.9k
Brian Gladden
Independent Director1.3yrsUS$320.00k0.0030%
$ 99.1k
Gregory Lucier
Independent Chairman6yrsUS$495.00k0.046%
$ 1.5m
William Deese
Independent Director14.3yrsUS$340.00k0.018%
$ 583.6k
Michael Barber
Independent Directorless than a yearsin datossin datos
Janet Vergis
Independent Director5.7yrsUS$335.00k0.011%
$ 363.6k
Jonathan Mazelsky
Independent Director2yrsUS$320.00k0.0028%
$ 91.5k
Daniel Scavilla
Independent Directorless than a yearsin datossin datos
4.7yrs
Permanencia media
63yo
Promedio de edad

Junta con experiencia: La junta directiva de XRAY se considera experimentada (4.7 años de antigüedad promedio).


Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2025/05/20 21:46
Precio de las acciones al final del día2025/05/20 00:00
Beneficios2025/03/31
Ingresos anuales2024/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

DENTSPLY SIRONA Inc. está cubierta por 34 analistas. 17 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Jeffrey JohnsonBaird
Lawrence MarshBarclays
Michael PetuskyBarrington Research Associates, Inc.